Adial recasts 2022 and 2021 financials to reflect Purnovate discontinued ops after sale

ADIAL PHARMACEUTICALS, INC.

Completed sale of Purnovate assets and business to Adovate, LLC on June 30, 2023.
Historical Purnovate results now shown as discontinued operations for 2022 and 2021.
Only Item 7 (MD&A) and Item 8 (Financial Statements) are revised; other 10-K sections unchanged.
Company directs investors to Q1 and Q2 2023 Form 10-Qs for more recent developments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.